Robert C. Koski

Robert C. Koski (board member) discloses dealings in 3 companies, chiefly Oragenics Inc, Helios Technologies, Inc. and LKA GOLD Inc /DE/. We count 43 filings; the first trade dates from 30 December 2009 and the latest from 11 December 2024.

On the open market, the record shows 12 purchases worth €432k and 26 sales worth €2.1M. Sales outweigh purchases by €1.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant and 1 option exercise.

The median purchase comes to €1,736. None of the 12 purchases we analysed coincided with buying by another insider of the same company within 30 days. For 12 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -9.2%. These figures describe past trades and do not predict future prices.

Most recently, on 13 December 2024, the filings show a transaction in Oragenics Inc. The most recent open-market purchase was published on 3 January 2022, 1,770 days ago. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.